Can Global Markets Adapt to the Ripple Effects of US Pricing Policy?
2026/05/21 | The Evidence Base
ISPOR 2026 Daily Round-Ups: Insights From Day 3
2026/05/21 | The Evidence Base
Can Healthcare Systems Balance Cancer Care Costs With Access and Innovation?
2026/05/20 | The Evidence Base
ISPOR 2026 Daily Round-Ups: Insights From Day 2
2026/05/20 | The Evidence Base
The True Cost of Cancer
2026/05/20 | Navlin Daily
Can US Drug Pricing Reforms Balance Affordability with Incentives for Innovation?
2026/05/19 | The Evidence Base
ISPOR 2026 Daily Round-Ups: Insights From Day 1
2026/05/19 | The Evidence Base
Is US Pharmaceutical Policy Leading or Following?
2026/05/19 | Navlin Daily
Your Guide to ISPOR 2026 - Key Themes and Program Highlights
2026/05/15 | The Evidence Base
Regeneron Inks White House Pricing Deal, Offers New Gene Therapy for Free
2026/05/14 | Pharmaceutical Technology
China’s New Drug Pricing Guidelines Aim to Reward Biotech Industry Innovation
2026/05/14 | South China Morning Post
Fairer Pricing of New Drugs Could Save European Union Up to €27 Billion Per Year
2026/05/14 | PharmacoEconomics
Aid Defunding Could Lead to Death Toll in LMICs That Exceeds Pandemic Numbers
2026/05/14 | Lancet Global Health
New Pancreatic Cancer Drug Doubles 1-Year Survival in Phase 2 Clinical Trial
2026/05/14 | Northwestern University
National Reimbursement Decisions Delay Access for Drugs Fast-Tracked by EMA
2026/05/14 | Journal of Pharmaceutical Policy and Practice
Claims Data Suggest Lower Risk of Dementia in Seniors After High-Dose Flu Vaccine
2026/05/14 | (Neurology
Limiting Food Plastics Touchpoints Decreases Chemical Levels in 7 Days
2026/05/14 | Nature Medicine
Healthcare Reclaims Top Spot Among US Domestic Worries in Gallup Poll
2026/05/14 | Gallup
- 1 (current)
- 2
- 3
- 4
- 5
Subscribe to the HEOR News Desk
SubscribeAlready have an ISPOR Profile? Click here to manage your subscriptions.